Sex differences in antibody responses to the 23-valent pneumococcal polysaccharide vaccination.
作者信息
Chiarella Sergio E, Jenkins Sarah M, Park Miguel A, Abraham Roshini S, Joshi Avni Y
机构信息
Division of Allergic Diseases, Mayo Clinic, Rochester, Minnesota.
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
出版信息
Ann Allergy Asthma Immunol. 2021 Oct;127(4):509-510. doi: 10.1016/j.anai.2021.07.013. Epub 2021 Jul 20.
Abstract
摘要
相似文献
1
Sex differences in antibody responses to the 23-valent pneumococcal polysaccharide vaccination.
Ann Allergy Asthma Immunol. 2021 Oct;127(4):509-510. doi: 10.1016/j.anai.2021.07.013. Epub 2021 Jul 20.
2
Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial.
Hum Vaccin Immunother. 2017 Sep 2;13(9):2065-2071. doi: 10.1080/21645515.2017.1331796.
3
Time interval of revaccination with 23-valent pneumococcal polysaccharide vaccine more than 5 years does not affect the immunogenicity and safety in the Japanese elderly.
Hum Vaccin Immunother. 2018;14(8):1931-1938. doi: 10.1080/21645515.2018.1456611. Epub 2018 May 14.
4
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.
Vaccine. 2019 Sep 30;37(42):6201-6207. doi: 10.1016/j.vaccine.2019.08.048. Epub 2019 Sep 5.
5
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults.
Hum Vaccin. 2011 Sep;7(9):919-28. doi: 10.4161/hv.7.9.15996. Epub 2011 Sep 1.
6
Immunogenicity and safety of the 13-valent Pneumococcal Conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and pre-immunized patients under treatment with chronic haemodialysis: a longitudinal quasi-experimental phase IV study.
Clin Microbiol Infect. 2018 Jan;24(1):65-71. doi: 10.1016/j.cmi.2017.05.016. Epub 2017 May 27.
7
Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older.
Vaccine. 2013 Aug 2;31(35):3594-602. doi: 10.1016/j.vaccine.2013.04.084. Epub 2013 May 18.
8
Theory and strategy for Pneumococcal vaccines in the elderly.
Hum Vaccin Immunother. 2016;12(2):336-43. doi: 10.1080/21645515.2015.1075678.
9
13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study.
Pediatr Blood Cancer. 2015 Aug;62(8):1427-36. doi: 10.1002/pbc.25502. Epub 2015 Mar 23.
10
Immunogenicity of the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults With and Without Comorbidities in the Community-Acquired Pneumonia Immunization Trial in Adults (CAPiTA).
Clin Infect Dis. 2017 Sep 1;65(5):787-795. doi: 10.1093/cid/cix419.
引用本文的文献
1
Assessment of naturally acquired IgG antibodies to pneumococcal vaccine serotypes in healthy and type 2 diabetic adults in India.
Clin Exp Vaccine Res. 2025 Jul;14(3):267-275. doi: 10.7774/cevr.2025.14.e25. Epub 2025 May 22.
2
Sex Differences in Lung B Cell Responses in a Murine Model of Asthma.
Int Arch Allergy Immunol. 2025 Apr 29:1-12. doi: 10.1159/000546024.
3
Sex-based difference in immune responses and efficacy of the pneumococcal conjugate vaccine.
J Leukoc Biol. 2024 Dec 31;117(1). doi: 10.1093/jleuko/qiae177.
4
Sex and gender differences in community-acquired pneumonia.
Intern Emerg Med. 2022 Sep;17(6):1575-1588. doi: 10.1007/s11739-022-02999-7. Epub 2022 Jul 19.
本文引用的文献
1
Pneumococcal serotype-specific cut-offs based on antibody responses to pneumococcal polysaccharide vaccination in healthy adults.
Vaccine. 2021 May 18;39(21):2850-2856. doi: 10.1016/j.vaccine.2021.04.015. Epub 2021 Apr 22.
2
Pneumococcal vaccination responses in adults with subnormal IgG subclass concentrations.
BMC Immunol. 2019 Aug 20;20(1):29. doi: 10.1186/s12865-019-0310-3.
3
Specific Antibody Deficiency: Controversies in Diagnosis and Management.
Front Immunol. 2017 May 22;8:586. doi: 10.3389/fimmu.2017.00586. eCollection 2017.
4
Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015.
Euro Surveill. 2017 Mar 9;22(10). doi: 10.2807/1560-7917.ES.2017.22.10.30481.
5
Sex differences in immune responses.
Nat Rev Immunol. 2016 Oct;16(10):626-38. doi: 10.1038/nri.2016.90. Epub 2016 Aug 22.
6
Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in Chinese healthy population aged >2 years: A randomized, double-blinded, active control, phase III trial.
Hum Vaccin Immunother. 2015;11(10):2425-33. doi: 10.1080/21645515.2015.1055429.
7
Sex-based differences in immune function and responses to vaccination.
Trans R Soc Trop Med Hyg. 2015 Jan;109(1):9-15. doi: 10.1093/trstmh/tru167.
8
Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology.
J Allergy Clin Immunol. 2012 Sep;130(3 Suppl):S1-24. doi: 10.1016/j.jaci.2012.07.002.
9
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
Arch Intern Med. 2008 Dec 8;168(22):2405-14. doi: 10.1001/archinternmed.2008.513.
10
Sexual dimorphism of humoral immunity with human vaccines.
Vaccine. 2008 Jul 4;26(29-30):3551-5. doi: 10.1016/j.vaccine.2008.04.054. Epub 2008 May 9.
Zotero 插件